Hiroshige Ohashi

506 total citations
34 papers, 389 citations indexed

About

Hiroshige Ohashi is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hiroshige Ohashi has authored 34 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 13 papers in Cardiology and Cardiovascular Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hiroshige Ohashi's work include Dialysis and Renal Disease Management (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Renin-Angiotensin System Studies (4 papers). Hiroshige Ohashi is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Renin-Angiotensin System Studies (4 papers). Hiroshige Ohashi collaborates with scholars based in Japan. Hiroshige Ohashi's co-authors include Michiya Ohno, Hiroshi Oda, Shinya Minatoguchi, Hisayoshi Fujiwara, Sachiro Watanabe, Nobuyuki Takada, Hiroyasu Ito, Shigeki Sakata, Takako Fujiwara and Genzou Takemura and has published in prestigious journals such as PLoS ONE, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Hiroshige Ohashi

33 papers receiving 378 citations

Peers

Hiroshige Ohashi
Paul Leurs Netherlands
Yume Nagaoka Japan
Konstantinos Mavromatidis Greece
Lotte Pietraszek Denmark
Takaharu Matsuda Japan
Attilio Losito Italy
Meiyu Cui China
Amin Roshdy Soliman Egypt
Fitsum Guebre-Egziabher France
E. Pardini Italy
Paul Leurs Netherlands
Hiroshige Ohashi
Citations per year, relative to Hiroshige Ohashi Hiroshige Ohashi (= 1×) peers Paul Leurs

Countries citing papers authored by Hiroshige Ohashi

Since Specialization
Citations

This map shows the geographic impact of Hiroshige Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshige Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshige Ohashi more than expected).

Fields of papers citing papers by Hiroshige Ohashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshige Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshige Ohashi. The network helps show where Hiroshige Ohashi may publish in the future.

Co-authorship network of co-authors of Hiroshige Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshige Ohashi. A scholar is included among the top collaborators of Hiroshige Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshige Ohashi. Hiroshige Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naito, Junko, Hiroshige Ohashi, Michiya Ohno, et al.. (2019). Long-Term Levocarnitine Ameliorates Left Ventricular Diastolic as Well as Systolic Dysfunction in Hemodialysis Patients　― Multi-Center Study ―. Circulation Reports. 1(11). 508–516. 4 indexed citations
2.
3.
Ohno, Michiya, Hiroshi Sarui, Akihiko Sasaki, et al.. (2014). Correlation between Renal Function and Common Risk Factors for Chronic Kidney Disease in a Healthy Middle-Aged Population: A Prospective Observational 2-Year Study. PLoS ONE. 9(11). e113263–e113263. 9 indexed citations
4.
Miyazaki, Nagisa, Ichijiro Murata, Genzou Takemura, et al.. (2014). Expression of prorenin receptor in renal biopsies from patients with IgA nephropathy.. PubMed. 7(11). 7485–96. 8 indexed citations
5.
Ito, Yasuhiko, Masashi Mizuno, Yasuhíro Suzuki, et al.. (2013). Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients. Journal of the American Society of Nephrology. 25(5). 1094–1102. 65 indexed citations
6.
7.
Minatoguchi, Shinya, et al.. (2008). Dual blockade of the rennin–angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis. Clinical and Experimental Nephrology. 12(1). 33–40. 8 indexed citations
8.
Kato, Yoko, et al.. (2007). Efficacy and pleiotropic effects of a new HMG-CoA reductase inhibitor, Rosuvastatin, in peritoneal dialysis patients with dyslipidemia. Nihon Toseki Igakkai Zasshi. 40(9). 781–787. 1 indexed citations
9.
ABE, Hirohiko, Shinya Minatoguchi, Hiroshige Ohashi, et al.. (2007). Renoprotective Effect of the Addition of Losartan to Ongoing Treatment with an Angiotensin Converting Enzyme Inhibitor in Type-2 Diabetic Patients with Nephropathy. Hypertension Research. 30(10). 929–935. 15 indexed citations
10.
Takemura, Genzou, Ken-ichiro Kosai, Ichijiro Murata, et al.. (2005). Hepatocyte Growth Factor Gene Therapy Slows Down the Progression of Diabetic Nephropathy in <i>db/db</i> Mice. Nephron Physiology. 102(3-4). p92–p102. 24 indexed citations
11.
Minatoguchi, Shinya, Hirotake Sano, Ichijiro Murata, et al.. (2004). Involvement of apoptosis in patients with diabetic nephropathy: A study on plasma soluble Fas levels and pathological findings. Nephrology. 9(2). 94–99. 14 indexed citations
12.
Takada, Nobuyuki, et al.. (2003). C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. American Journal of Kidney Diseases. 42(2). 355–361. 39 indexed citations
13.
Ikeda, Masahiro, et al.. (2001). Angiographic assessment of surgical reconstructions for left ventricular asynergy with indices of abnormally contracting segments.. PubMed. 7(6). 346–51. 1 indexed citations
14.
Matsumoto, Yoshihiro, Motoyoshi Sato, Hiroshige Ohashi, et al.. (2000). Effects of <i>L</i>-Carnitine Supplementation on Cardiac Morbidity in Hemodialyzed Patients. American Journal of Nephrology. 20(3). 201–207. 49 indexed citations
15.
Ohashi, Hiroshige, Hiroshi Oda, Michiya Ohno, Sachiro Watanabe, & Shigeki Sakata. (1999). Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients. Kidney International. 56. S242–S244. 34 indexed citations
16.
Hayakawa, Yukihiro, Genzou Takemura, Jun Misao, et al.. (1999). Apoptosis and Overexpression of Bax Protein and bax mRNA in Smooth Muscle Cells Within Intimal Hyperplasia of Human Radial Arteries. Arteriosclerosis Thrombosis and Vascular Biology. 19(9). 2066–2077. 19 indexed citations
17.
Sano, Hirotake, Shinya Minatoguchi, Kazuhiko Nishigaki, et al.. (1998). Plasma Soluble Fas and Soluble Fas Ligand in ChronicGlomerulo nephritis. ˜The œNephron journals/Nephron journals. 80(2). 153–161. 16 indexed citations
18.
Matsuno, Yukihiko, et al.. (1994). Double filtration plasmapheresis was effective in the treatment of a case of pemphigus vulgaris with multiple organ failure.. Nihon Toseki Igakkai Zasshi. 27(7). 1091–1094.
19.
Ohashi, Hiroshige, Hiroshi Oda, Yukihiko Matsuno, et al.. (1991). Clinical significance of .ALPHA.-human atrial natriuretic peptide in patients on maintenance dialysis.. Journal of Japanese Society for Dialysis Therapy. 24(1). 43–47. 1 indexed citations
20.
Ohashi, Hiroshige, et al.. (1986). Acute renal failure caused by nontraumatic rhabdomyolysis. Journal of Japanese Society for Dialysis Therapy. 19(10). 957–962. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Leurs Breakdown of academic impact, for papers by Yume Nagaoka Breakdown of academic impact, for papers by Konstantinos Mavromatidis Breakdown of academic impact, for papers by Lotte Pietraszek Breakdown of academic impact, for papers by Takaharu Matsuda Breakdown of academic impact, for papers by Attilio Losito Breakdown of academic impact, for papers by Meiyu Cui Breakdown of academic impact, for papers by Amin Roshdy Soliman Breakdown of academic impact, for papers by Fitsum Guebre-Egziabher Breakdown of academic impact, for papers by E. Pardini
Rankless by CCL
2026